Wells Fargo & Company MN Sells 10,280 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Wells Fargo & Company MN lessened its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 0.8% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,310,347 shares of the medical device company’s stock after selling 10,280 shares during the quarter. Wells Fargo & Company MN owned approximately 0.66% of Cooper Companies worth $120,460,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Byrne Asset Management LLC bought a new position in shares of Cooper Companies in the fourth quarter worth about $33,000. OFI Invest Asset Management bought a new position in Cooper Companies in the 4th quarter worth about $34,000. New Age Alpha Advisors LLC purchased a new position in shares of Cooper Companies during the fourth quarter worth approximately $38,000. West Financial Advisors LLC bought a new stake in shares of Cooper Companies during the fourth quarter valued at approximately $49,000. Finally, Atala Financial Inc purchased a new stake in shares of Cooper Companies in the fourth quarter valued at approximately $51,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Down 5.6 %

Shares of COO stock opened at $73.77 on Monday. The stock’s fifty day moving average price is $87.76 and its 200 day moving average price is $96.14. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a 1-year low of $73.34 and a 1-year high of $112.38. The company has a market cap of $14.75 billion, a price-to-earnings ratio of 37.83, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.92. The firm had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. On average, research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have weighed in on COO. JPMorgan Chase & Co. decreased their target price on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating for the company in a research report on Friday, March 7th. BNP Paribas raised shares of Cooper Companies to a “hold” rating in a research report on Thursday, March 13th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research report on Friday, March 7th. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Finally, Stifel Nicolaus lowered their target price on Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, Cooper Companies currently has an average rating of “Moderate Buy” and a consensus price target of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.